Nova Molecular Inc.

Nova Molecular Inc. (NMI) is a Montreal based CNS drug discovery company focused on understanding neuronal degeneration, disease progression, repair mechanisms, therapeutic response and development based on our proprietary neuron repair biology platform. NMI’s lead Alzheimer’s compound is also under investigation for a number of other CNS neurodegenerative indications such as Parkinson’s, multiple sclerosis, ALS, infections of the CNS, Stroke and trauma....The company has a number of active collaborations and partnerships including Variagenics, Geneka, McGill University, USC, Clinical Microsensors, and Layton Biosciences

Activity:

Product / Technology type(s) covered:

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: